Aileron Therapeutics Inc. (ALRN)
NASDAQ: ALRN
· Real-Time Price · USD
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 10:00 PM
Aileron Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 126K | 126K | 126K | 134K | 134K | 134K | 134K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 63K | 67K | 126K | 115K | 127K | 135K | 119K | 110K | 98K | 128K | 126K | 123K | 162K | 160K | 121K | 81K | 42K | 2K |
Gross Profit | 63K | 59K | n/a | 19K | 7K | -1K | 15K | -110K | -98K | -128K | -126K | -123K | -162K | -160K | -121K | -81K | -42K | -2K |
Operating Income | -61.35M | -63.52M | -65.11M | -29.62M | -25.53M | -18.48M | -16.29M | -13.69M | -18.19M | -24.24M | -27.65M | -29.76M | -30.07M | -28.04M | -26.61M | -23.98M | -22.22M | -20.61M |
Interest Income | n/a | n/a | n/a | 78K | 233K | 345K | 400K | 442K | 397K | 334K | 300K | 180K | 91K | 61K | 54K | 54K | 38K | 29K |
Pretax Income | -59.15M | -61.27M | -62.88M | -29.24M | -25.22M | -18.07M | -15.73M | -12.94M | -17.48M | -23.69M | -27.33M | -29.62M | -29.96M | -27.65M | -26.2M | -24.36M | -22.68M | -21.38M |
Net Income | -59.15M | -61.27M | -62.88M | -29.24M | -25.22M | -18.07M | -15.5M | -12.55M | -17.09M | -23.25M | -27.13M | -29.53M | -29.87M | -27.61M | -26.16M | -24.36M | -22.68M | -21.38M |
Selling & General & Admin | 9.96M | 12.68M | 13.86M | 16.67M | 16.27M | 12.87M | 11.3M | 8.33M | 8.62M | 9.33M | 9.68M | 9.63M | 9.9M | 9.45M | 9.6M | 9.61M | 9.44M | 9.2M |
Research & Development | 14.39M | 13.84M | 14.25M | 12.9M | 9.2M | 5.64M | 3.99M | 4.42M | 8.64M | 13.88M | 17.97M | 20.13M | 20.16M | 18.59M | 17.01M | 14.37M | 12.78M | 11.41M |
Other Expenses | n/a | n/a | n/a | n/a | 1K | 1K | 178K | 178K | 181K | 181K | -18K | -18K | 44K | 44K | 66K | 66K | n/a | n/a |
Operating Expenses | 24.35M | 26.52M | 28.11M | 29.57M | 25.47M | 18.51M | 15.3M | 12.75M | 17.25M | 23.21M | 27.65M | 29.76M | 30.07M | 28.04M | 26.61M | 23.98M | 22.22M | 20.61M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | -52K | -52K | -52K | -52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.93M | 20.97M | 28.18M | 29.62M | 25.52M | 18.56M | 15.35M | 12.75M | 17.25M | 23.21M | 27.65M | 29.76M | 30.07M | 28.04M | 26.61M | 23.98M | 22.22M | 20.61M |
Income Tax Expense | 59K | 59K | n/a | 522K | 522K | 522K | 349K | -388K | -388K | -437K | -204K | -35K | -56K | -26K | -27K | -40K | -19K | n/a |
Shares Outstanding (Basic) | 24.19K | 21.92M | 19.8M | 21.66M | 19.91M | 8.3M | 4.77M | 4.54M | 4.54M | 4.54M | 4.54M | 4.54M | 4.54M | 4.53M | 4.53M | 4.53M | 4.52M | 4.17M |
Shares Outstanding (Diluted) | 24.19K | 21.92M | 19.8M | 21.66M | 19.91M | 8.3M | 4.77M | 4.54M | 4.54M | 4.54M | 4.54M | 4.54M | 4.54M | 4.53M | 4.53M | 4.53M | 4.52M | 4.17M |
EPS (Basic) | -2.87 | -3.04 | -3.65 | -3.12 | -3.25 | -3.19 | -3.33 | -2.76 | -3.76 | -5.12 | -5.98 | -6.51 | -6.59 | -6.1 | -5.91 | -7.1 | -8.17 | -9.72 |
EPS (Diluted) | -2.87 | -3.04 | -3.65 | -3.12 | -3.25 | -3.19 | -3.33 | -2.76 | -3.76 | -5.12 | -5.98 | -6.51 | -6.59 | -6.1 | -5.91 | -7.1 | -8.17 | -9.72 |
EBITDA | -59.54M | -61.7M | -63.24M | -29.5M | -25.4M | -18.43M | -15.23M | -12.64M | -17.11M | -23.04M | -27.48M | -29.59M | -29.91M | -27.88M | -26.48M | -23.89M | -22.15M | -20.51M |
EBIT | 16.24M | 7.21M | n/a | -29.62M | -25.52M | -18.56M | -15.35M | -12.75M | -17.25M | -23.21M | -27.65M | -29.76M | -30.07M | -28.04M | -26.61M | -23.98M | -22.22M | -20.61M |
Depreciation & Amortization | -63K | -59K | n/a | 115K | 127K | 135K | 119K | 110K | 141K | 171K | 169K | 166K | 162K | 160K | 121K | 91K | 66K | 95K |